BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
OCULUS INNOV SCI (NQ: OCLS)
3.920 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
(OCLS) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 22, 2013
(ValueWalk.com, 8/28/12)
D.E Shaw & Co. , one of the world's largest hedge funds with a total portfolio valued at over $39 billion, added Coca-Cola Company (NYSE:KO) and the hedge fund favorite, News Corp...(read more)
(Benzinga, 11/4/10)
Oculus Innovative Sciences Reports Record Revenue in Second Quarter Fiscal-Year 2011, Exceeding Guidance Q2 FY 2011 Results: * Total Revenue of $2.5 Million * Product Revenue Increased 63% * Loss Narrows - Net Losses...(read more)
Bloomberg - D.E. Shaw & Co. LP, the investment firm run by David Shaw, and Farallon Capital Management LLC limited withdrawals by clients, joining more than 80 hedge-fund...(read more)
Oculus Innovative Sciences (OCLS) Company Overview

There is no analysis for OCLS yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here